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FIGURE 1 Potentia
With Severe Aortic
AVR ¼ aortic valve re
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and Valve GuidelinesThe review by Galli et al. (1) provides an important
overview of left ventricular mechanics in common
valvular diseases. At the same time, for a practicing
cardiologist it is important that this information isl Role of Global Longitudinal Strain in the Management of Patients
Stenosis According to Flow-Gradient Pattern
placement; ETT ¼ exercise testing; GLS ¼ global longitudinal
LG¼ lowgradient; LVEF¼ left ventricular ejection fraction;MG¼mean
lﬂow;NG¼normal gradient; SVI¼ stroke volume index; Vel¼velocity.presented in the context of the current valvular dis-
ease guidelines to highlight the areas where clinical
decision making can be augmented by this additional
information (2). As a relevant example, the algorithm
for the management of patients with severe aortic
stenosis (Figure 8 in Galli et al. [1]) is confusing. An
alternative diagram is presented in Figure 1 which
integrates the current guidelines with evolving
knowledge as well as highlights important gaps. The
normal ﬂow/low gradient group is not properly
deﬁned because the guidelines prioritize the velocity/
gradient approach over the aortic area measurement.
In these cases careful measurement veriﬁcation is
important, such as obtaining proper outﬂow tract area
and indexing valve area to body surface area. Also,
one should bear in mind that in a normal ﬂow state a
mean gradient of 40 mm Hg corresponds to an aortic
valve area of <0.8 cm2, so there is inherent discrep-
ancy with the old deﬁnition of severe aortic stenosis
(valve area of <1 cm2) (2). In this challenging group,
longitudinal strain measurement and calcium scoring
may provide valuable information. In the groups of
patients with high gradients regardless of ﬂow state,
the guidelines are mostly explicit and unequivocal.
In the low ﬂow/low gradient group, left ventricular
ejection fraction (LVEF) is an important deﬁning
factor. Patients in this group who have decreased
LVEF should probably undergo dobutamine infusion
to identify true severe stenosis and assess contractile
reserve. Patients in the low ﬂow/low gradient group
with normal LVEF need repeat measurements after
adequate blood pressure control and they may also
beneﬁt from longitudinal strain measurement and
calcium scoring. Unlike the recommendation by Galli
et al. (1), dobutamine infusion is not supported by
substantial evidence in this subgroup (2).Edgar Argulian, MD, MPH*
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